Roberto Leon Ferre in Rochester, Minnesota

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Roberto Leon Ferre is listed as: Medical Oncology
Approximate Years of Experience: 17
PAC (PECOS ID)#: 4587805999
NPI #: 1427361377
NPI Created On: 07/21/2010
NPI Last Updated Listed as: 08/18/2020
Primary Taxonomy Code: 207R00000X
License Number:
40765
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medica Health Plans of Wisconsin
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Hydration infusion into a vein
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
7. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
8. Infusion of different chemotherapy drug or substance into a vein
9. Infusion of chemotherapy into a vein up to 1 hour
10. Infusion of chemotherapy into a vein
11. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
12. Established patient office or other outpatient, visit typically 25 minutes
13. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
14. Injection, atropine sulfate, 0.01 mg
15. Injection, leucovorin calcium, per 50 mg
16. Injection, dexamethasone sodium phosphate, 1 mg
17. Injection, diphenhydramine hcl, up to 50 mg
18. Injection, fosaprepitant, 1 mg
19. Injection, ondansetron hydrochloride, per 1 mg
20. Injection, palonosetron hcl, 25 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).